Skip to main content
SpringerLink
Log in

Pharmacology in Cardiopulmonary Resuscitation

  • Chapter
Acute Heart Failure

  • 2413 Accesses

Abstract

The number of drugs available for cardiopulmonary resuscitation (CPR) is limited, and there are few data regarding their use. Furthermore, no drug should be administered before performing electric shocks when indicated and before starting chest compressions. A recent large study performed by Stiell et al. (1) showed that advanced cardiac life support is a less important parameter that positively influences outcome of patients in cardiac arrest.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stiell IG, Wells GA, Field B, et al.: Ontario Prehospital Advanced Life Support Study Group: Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med 2004;351:647–56.

    Article  CAS  PubMed  Google Scholar 

  2. Gueugniaud PY, Mols P, Goldstein P, et al.: A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. N Engl J Med 1998;339:1595–601.

    Article  CAS  PubMed  Google Scholar 

  3. Lindner KH, Strohmenger HU, Ensinger H, Hetzel WD, Ahnefeld FW, Georgieff M: Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992;77:662–8.

    Article  CAS  PubMed  Google Scholar 

  4. Lindner KH, Haak T, Keller A, Bothner U, Lurie KG: Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 1996;75:145–50.

    Article  CAS  PubMed  Google Scholar 

  5. Lindner KH, Brinkmann A, Pfenninger EG, Lurie KG, Goertz A, Lindner IM: Effect of vasopressin on hemodynamic variables, organ blood flow, and acid-base status in a pig model of cardiopulmonary resuscitation. Anesth Analg 1993;77:427–35.

    Article  CAS  PubMed  Google Scholar 

  6. Lindner KH, Prengel AW, Pfenninger EG, et al.: Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995;91:215–21.

    CAS  PubMed  Google Scholar 

  7. Wenzel V, Lindner KH, Prengel AW, et al.: Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs. Crit Care Med 1999;27:486–92.

    Article  CAS  PubMed  Google Scholar 

  8. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG: Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996;124:1061–4.

    CAS  PubMed  Google Scholar 

  9. American Heart Association in collaboration with International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science: Section 6. Pharmacology II: agents to Optimize Cardiac Output and Blood Pressure. Circulation 2000;102(suppl I):I129–35.

    Google Scholar 

  10. Stiell IG, Hebert PC, Wells GA, et al.: Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet 2001;358:105–9.

    Article  CAS  PubMed  Google Scholar 

  11. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH: A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004;350:105–13.

    Article  CAS  PubMed  Google Scholar 

  12. Mayr VD, Wenzel V, Voelckel WG, et al.: Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation 2001;104:1651–6.

    Article  CAS  PubMed  Google Scholar 

  13. Voelckel WG, Lurie KG, McKnite S, et al.: Effects of epinephrine and vasopressin in a piglet model of prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med 2002;30:957–62.

    Article  CAS  PubMed  Google Scholar 

  14. Aung K, Htay T: Vasopressin for cardiac arrest: a systematic review and meta-analysis. Arch Intern Med 2005;165:17–24.

    Article  CAS  PubMed  Google Scholar 

  15. Callaham M, Madsen CD, Barton CW, Saunders CE, Pointer J: A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. JAMA 1992;268:2667–72.

    Article  CAS  PubMed  Google Scholar 

  16. Klouche KWM, Sun S, Tang W, Zhao DH: A comparison of alpha-methylnorepinephrine, vasopressin and epinephrine for cardiac resuscitation. Resuscitation 2003;57:93–100.

    Article  CAS  PubMed  Google Scholar 

  17. Hilwig RW, Berg RA, Kern KB, Ewy GA: Endothelin-1 vasoconstriction during swine cardiopulmonary resuscitation improves coronary perfusion pressures but worsens postresuscitation outcome. Circulation 2000;101:2097–102.

    CAS  PubMed  Google Scholar 

  18. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A: Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002;346:884–90.

    Article  CAS  PubMed  Google Scholar 

  19. Kudenchuk PJ, Cobb LA, Copass MK, et al.: Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871–8.

    Article  CAS  PubMed  Google Scholar 

  20. Somberg JC, Timar S, Bailin SJ, et al.: Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am J Cardiol 2004;93:576–81.

    Article  CAS  PubMed  Google Scholar 

  21. Skrifvars MB, Kuisma M, Boyd J, et al.: The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 2004;48:582–7.

    Article  CAS  PubMed  Google Scholar 

  22. Petrovic T, Adnet F, Lapandry C: Successful resuscitation of ventricular fibrillation after low-dose amiodarone. Ann Emerg Med 1998;32:518–9.

    CAS  PubMed  Google Scholar 

  23. Levine JH, Massumi A, Scheinman MM, et al.: Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol 1996;27:67–75.

    Article  CAS  PubMed  Google Scholar 

  24. Matsusaka T, Hasebe N, Jin YT, Kawabe J, Kikuchi K: Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits. Cardiovasc Res 2002;54:568–75.

    Article  CAS  PubMed  Google Scholar 

  25. Thel MC, Armstrong AL, McNulty SE, Califf RM, O’Connor CM: Randomised trial of magnesium in in-hospital cardiac arrest. Lancet 1997;350:1272–6.

    Article  CAS  PubMed  Google Scholar 

  26. Allegra J, Lavery R, Cody R, et al.: Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resuscitation 2001;49:245–9.

    Article  CAS  PubMed  Google Scholar 

  27. Fatovich D, Prentice D, Dobb G: Magnesium in in-hospital cardiac arrest. Lancet 1998;351:446.

    Article  CAS  PubMed  Google Scholar 

  28. Hassan TB, Jagger C, Barnett DB: A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med J 2002;19:57–62.

    Article  CAS  PubMed  Google Scholar 

  29. Miller B, Craddock L, Hoffenberg S, et al.: Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for future studies. Resuscitation 1995;30:3–14.

    Article  CAS  PubMed  Google Scholar 

  30. Longstreth WT Jr, Fahrenbruch CE, Olsufka M, Walsh TR, Copass MK, Cobb LA: Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest. Neurology 2002;59:506–14.

    CAS  PubMed  Google Scholar 

  31. Baraka A, Ayoub C, Kawkabani N: Magnesium therapy for refractory ventricular fibrillation. J Cardiothorac Vasc Anesth 2000;14:196–9.

    Article  CAS  PubMed  Google Scholar 

  32. Stiell IG, Wells GA, Hebert PC, Laupacis A, Weitzman BN: Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life supportdrugs. Acad Emerg Med 1995;2:264–73.

    Article  CAS  PubMed  Google Scholar 

  33. Engdahl J, Bang A, Lindqvist J, Herlitz J: Can we define patients with no and those with some chance of survival when found in asystole out of hospital? Am J Cardiol 2000;86:610–4.

    Article  CAS  PubMed  Google Scholar 

  34. Engdahl J, Bang A, Lindqvist J, Herlitz J: Factors affecting short-and long-term prognosis among 1069 patients with out-of-hospital cardiac arrest and pulseless electrical activity. Resuscitation 2001;51:17–25.

    Article  CAS  PubMed  Google Scholar 

  35. Dumot JA, Burval DJ, Sprung J, et al.: Outcome of adult cardiopulmonary resuscitations at a tertiary referral center including results of “limited” resuscitations. Arch Intern Med 2001;161:1751–8

    Article  CAS  PubMed  Google Scholar 

  36. Dumot J, Burva LD, Sprung J, et al.: Outcome of adult cardiopulmonary resuscitations at a tertiary referral center including results of “limited” resuscitations. Arch Intern Med 2001;161:1751–8

    Article  CAS  PubMed  Google Scholar 

  37. Viskin S, Belhassen B, Roth A, et al.: Aminophylline for bradyasystolic cardiac arrest refractory to atropine and epinephrine. Ann Intern Med 1993;118:279–81.

    CAS  PubMed  Google Scholar 

  38. Mader TJ, Gibson P: Adenosine receptor antagonism in refractory asystolic cardiac arrest: results of a human pilot study. Resuscitation 1997;35:3–7.

    Article  CAS  PubMed  Google Scholar 

  39. Mader TJ, Smithline HA, Gibson P: Aminophylline in undifferentiated out-of-hospital asystolic cardiac arrest. Resuscitation 1999;41:39–45.

    Article  CAS  PubMed  Google Scholar 

  40. Mader TJ, Smithline HA, Durkin L, Scriver G: A randomized controlled trial of intravenous aminophylline for atropine-resistant out-of-hospital asystolic cardiac arrest. Acad Emerg Med 2003;10:192–7.

    Article  PubMed  Google Scholar 

  41. Dybvik T, Strand T, Steen PA: Buffer therapy during out-of-hospital cardiopulmonary resuscitation. Resuscitation 1995;29:89–95.

    Article  CAS  PubMed  Google Scholar 

  42. Aufderheide TP, Martin DR, Olson DW, et al.: Prehospital bicarbonate use in cardiac arrest: a 3-year experience. Am J Emerg Med 1992;10:4–7.

    Article  CAS  PubMed  Google Scholar 

  43. Delooz HH, Lewi PJ: Are inter-center differences in EMS-management and sodium-bicarbonate administration important for the outcome of CPR? The Cerebral Resuscitation Study Group. Resuscitation 1989;17(suppl):S161–72.

    Article  PubMed  Google Scholar 

  44. Roberts D, Landolfo K, Light RB, Dobson K: Early predictors of mortality for hospitalized patients suffering cardiopulmonary arrest. Chest 1990;97:413–9.

    Article  CAS  PubMed  Google Scholar 

  45. Suljaga-Pechtel K, Goldberg E, Strickon P, Berger M, Skovron ML: Cardiopulmonary resuscitation in a hospitalized population: prospective study of factors associated with outcome. Resuscitation 1984;12:77–95.

    Article  CAS  PubMed  Google Scholar 

  46. Weil MH, Trevino RP, Rackow EC: Sodium bicarbonate during CPR. Does it help or hinder? Chest 1985;88:487.

    Article  CAS  PubMed  Google Scholar 

  47. Bar-Joseph G, Abramson NS, Kelsey SF, Mashiach T, Craig MT, Safar P: Improved resuscitation outcome in emergency medical systems with increased usage of sodium bicarbonate during cardiopulmonary resuscitation. Acta Anaesthesiol Scand 2005;49:6–15.

    Article  CAS  PubMed  Google Scholar 

  48. Sandeman DJ, Alahakoon TI, Bentley SC: Tricyclic poisoning—successful management of ventricular fibrillation following massive overdose of imipramine. Anaesth Intensive Care 1997;25:542–5.

    CAS  PubMed  Google Scholar 

  49. Fischer M, Bottiger BW, Popov-Cenic S, Hossmann KA: Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 1996;22:1214–23.

    Article  CAS  PubMed  Google Scholar 

  50. Ruiz-Bailen M, Aguayo de Hoyos E, Serrano-Corcoles MC, Diaz-Castellanos MA, Ramos-Cuadra JA, Reina-Toral A: Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med 2001;27:1050–7.

    Article  CAS  PubMed  Google Scholar 

  51. Bottiger BW, Bode C, Kern S, et al.: Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001;357:1583–5.

    Article  CAS  PubMed  Google Scholar 

  52. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M: Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 2001;50:71–6.

    Article  CAS  PubMed  Google Scholar 

  53. Tiffany PA, Schultz M, Stueven H: Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: outcome of a case series. Ann Emerg Med 1998;31:124–6.

    Article  CAS  PubMed  Google Scholar 

  54. Abu-Laban RB, Christenson JM, Innes GD, et al.: Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002;346:1522–8.

    Article  CAS  PubMed  Google Scholar 

  55. Lederer W, Lichtenberger C, Pechlaner C, Kinzl J, Kroesen G, Baubin M: Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscitation 2004;61:123–9.

    Article  CAS  PubMed  Google Scholar 

  56. Bottiger BW, Martin E: Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation activation after cardiac arrest. Curr Opin Crit Care 2001;7:176–83.

    Article  CAS  PubMed  Google Scholar 

  57. Gueugniaud PY, Theurey O, Vaudelin T, Rochette M, Petit P: Peripheral versus central intravenous lines in emergency cardiac care. Lancet 1987;2:573.

    Article  CAS  PubMed  Google Scholar 

  58. Guy J, Haley K, Zuspan SJ: Use of intraosseous infusion in the pediatric trauma patient. J Pediatr Surg 1993;28:158–61.

    Article  CAS  PubMed  Google Scholar 

  59. Macnab A, Christenson J, Findlay J, et al.: A new system for sternal intraosseous infusion in adults. Prehosp Emerg Care 2000;4:173–7.

    Article  CAS  PubMed  Google Scholar 

  60. Hornchen U, Schuttler J, Stoeckel H, Eichelkraut W, Hahn N: Endobronchial instillation of epinephrine during cardiopulmonary resuscitation. Crit Care Med 1987;15:1037–9.

    Article  CAS  PubMed  Google Scholar 

  61. Niemann JT, Stratton SJ, Cruz B, Lewis RJ: Endotracheal drug administration during out-of-hospital resuscitation: where are the survivors? Resuscitation 2002;53:153–7.

    Article  PubMed  Google Scholar 

  62. Naganobu K, Hasebe Y, Uchiyama Y, Hagio M, Ogawa H: A comparison of distilled water and normal saline as diluents for endobronchial administration of epinephrine in the dog. Anesth Analg 2000;91:317–21.

    Article  CAS  PubMed  Google Scholar 

  63. Prengel AW, Rembecki M, Wenzel V, Steinbach G: A comparison of the endotracheal tube and the laryngeal mask airway as a route for endobronchial lidocaine administration. Anesth Analg 2001;92:1505–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, Lariboisière University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France

    Patrick I. Plaisance MD, PhD

  2. Department of Anesthesiology and Critical Care, Lariboisière University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France

    Claire Broche MD

  3. Department of Emergency Medicine, Lariboisière University Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France

    Karima Mezaïb MD

Authors
  1. Patrick I. Plaisance MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire Broche MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karima Mezaïb MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Anesthesiology and Critical Care Medicine, Lariboisière University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France

    Alexandre Mebazaa MD, PhD (Professor of Medicine) (Professor of Medicine)

  2. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Mihai Gheorghiade MD, FACC (Professor of Medicine and Surgery, Associate Chief, Division of Cardiology and Chief, Cardiology Clinical Service) (Professor of Medicine and Surgery, Associate Chief, Division of Cardiology and Chief, Cardiology Clinical Service)

  3. Department of Cardiology Centre d’Investigation Clinique (CIC), INSERM U-684, Centre Hospitalier Universitaire, University Henri Poincaré, Nancy, France

    Faiez M. Zannad MD, PhD, FESC (Professor of Medicine) (Professor of Medicine)

  4. Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Camden, NJ, USA

    Joseph E. Parrillo MD (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director) (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director)

  5. Cooper Heart Institute, Cooper University Hospital, Camden, NJ, USA

    Joseph E. Parrillo MD (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director) (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Plaisance, P.I., Broche, C., Mezaïb, K. (2008). Pharmacology in Cardiopulmonary Resuscitation. In: Mebazaa, A., Gheorghiade, M., Zannad, F.M., Parrillo, J.E. (eds) Acute Heart Failure. Springer, London. https://doi.org/10.1007/978-1-84628-782-4_75

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-782-4_75

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-781-7

  • Online ISBN: 978-1-84628-782-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation